Breast Cancer in Pregnancy Register Study (BCP)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00196833|
Recruitment Status : Recruiting
First Posted : September 20, 2005
Last Update Posted : August 2, 2017
Women who were diagnosed with breast cancer during their pregnancy may be registered in this trial.
Data is collected on the foetal outcome 4 weeks after delivery, maternal outcome of pregnancy as well as the breast cancer therapy applied (treatment, response to chemotherapy, type of surgery), diagnostic procedures applied (palpation, US, mammogram) and the outcome of mother and child after 5 years of therapy.
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||500 participants|
|Official Title:||Prospective and Retrospective Register Study of the German Breast Group (GBG) for Diagnosis and Treatment of Breast Cancer in Pregnancy|
|Study Start Date :||April 2003|
|Estimated Primary Completion Date :||April 2019|
|Estimated Study Completion Date :||April 2019|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00196833
|Contact: Sibylle Loibl, PD.MD||+49 6102-7480- ext 426||Sibylle.Loibl@gbg.de|
|German Breast Group||Recruiting|
|Neu Isenburg, Hessen, Germany, 63263|
|Contact: Sibylle Loibl, PD.MD +49 6102 7840 ext 426 Sibylle.Loibl@gbg.de|
|Principal Investigator: Sibylle Loibl, MD|
|Principal Investigator:||Sibylle Loibl, PD.MD||German Breast Group|